Description : Paras Biopharmaceuticals Finland Oy is an up-and-coming biopharmaceutical technology development company which has successfully developed the Diabrid Platform Technology proprietary for the high level
Description : M-Health Congress 2019 was an event designed to bring together different digital healthcare specialists for further development of the industry. The congress gathered representatives of public health,
Description : Net sales increased 1% to EUR 2.605 million (Q2 2018: 2.589 million) Comparable operating profit increased 3% to EUR 345 million (334 million)
